Pfizer
PFE
2,438 hedge funds and large institutions have $130B invested in Pfizer in 2020 Q1 according to their latest regulatory filings, with 126 funds opening new positions, 990 increasing their positions, 1,120 reducing their positions, and 181 closing their positions.
31% more funds holding in top 10
Funds holding in top 10: 107 → 140 (+33)
0.36% less ownership
Funds ownership: 76.09% → 75.73% (-0.36%)
3% less funds holding
Funds holding: 2,525 → 2,438 (-87)
12% less repeat investments, than reductions
Existing positions increased: 990 | Existing positions reduced: 1,120
17% less capital invested
Capital invested by funds: $157B → $130B (-$26.7B)
30% less first-time investments, than exits
New positions opened: 126 | Existing positions closed: 181
33% less call options, than puts
Call options by funds: $876M | Put options by funds: $1.31B
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital World Investors
Los Angeles,
California
|
+$1.3B |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
+$896M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$432M |
| 4 |
N
Nuveen
Charlotte,
North Carolina
|
+$346M |
| 5 |
D.E. Shaw & Co
New York
|
+$299M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fisher Asset Management
Camas,
Washington
|
-$1.43B |
| 2 |
Capital International Investors
Los Angeles,
California
|
-$495M |
| 3 |
Massachusetts Financial Services
Boston,
Massachusetts
|
-$453M |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$439M |
| 5 |
Goldman Sachs
New York
|
-$411M |
PFE Hedge Fund Activity: Q1 2020 in Review
2,438 of the 4,539 institutional investors tracked by Wall St. Rank reported a position in Pfizer (PFE) for Q1 2020, worth a combined $130B — down 17% from $157B a quarter earlier.
Sellers outnumbered buyers: 181 funds closed out of PFE and 126 opened new positions — a net loss of 55 holders — while 1,120 trimmed existing stakes and 990 added.
The largest buyer was Capital World Investors, adding an estimated $1.3B. The largest seller was Fisher Asset Management, cutting an estimated $1.43B.
- 2,438 institutional investors held Pfizer (PFE) as of Q1 2020, down from 2,525 in Q4 2019.
- Funds reported $130B of Pfizer stock for Q1 2020, down 17% quarter-over-quarter.
- 126 funds opened new Pfizer positions in Q1 2020 and 181 closed out, a net change of -55 holders.
- The largest Pfizer buyer in Q1 2020 was Capital World Investors, an estimated $1.3B added.
- The largest Pfizer seller in Q1 2020 was Fisher Asset Management, an estimated $1.43B sold.
Based on aggregated 13F filings for Q1 2020.